Brought to you by 
Illumina buys Helixis for $70mm plus earn-outs
16 Aug 2010
Executive Summary
Life sciences company Illumina Inc. has acquired privately held molecular diagnostics start-up Helixis Inc. for $70mm in cash up front and an additional $35mm in potential earn-outs.
Deal Industry
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com